Cargando…

COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess

Detalles Bibliográficos
Autores principales: Pivonello, Rosario, Ferrigno, Rosario, Isidori, Andrea M, Biller, Beverly M K, Grossman, Ashley B, Colao, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282791/
https://www.ncbi.nlm.nih.gov/pubmed/32531251
http://dx.doi.org/10.1016/S2213-8587(20)30215-1
_version_ 1783544189458317312
author Pivonello, Rosario
Ferrigno, Rosario
Isidori, Andrea M
Biller, Beverly M K
Grossman, Ashley B
Colao, Annamaria
author_facet Pivonello, Rosario
Ferrigno, Rosario
Isidori, Andrea M
Biller, Beverly M K
Grossman, Ashley B
Colao, Annamaria
author_sort Pivonello, Rosario
collection PubMed
description
format Online
Article
Text
id pubmed-7282791
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72827912020-06-10 COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess Pivonello, Rosario Ferrigno, Rosario Isidori, Andrea M Biller, Beverly M K Grossman, Ashley B Colao, Annamaria Lancet Diabetes Endocrinol Comment Elsevier Ltd. 2020-08 2020-06-09 /pmc/articles/PMC7282791/ /pubmed/32531251 http://dx.doi.org/10.1016/S2213-8587(20)30215-1 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Pivonello, Rosario
Ferrigno, Rosario
Isidori, Andrea M
Biller, Beverly M K
Grossman, Ashley B
Colao, Annamaria
COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
title COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
title_full COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
title_fullStr COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
title_full_unstemmed COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
title_short COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
title_sort covid-19 and cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282791/
https://www.ncbi.nlm.nih.gov/pubmed/32531251
http://dx.doi.org/10.1016/S2213-8587(20)30215-1
work_keys_str_mv AT pivonellorosario covid19andcushingssyndromerecommendationsforaspecialpopulationwithendogenousglucocorticoidexcess
AT ferrignorosario covid19andcushingssyndromerecommendationsforaspecialpopulationwithendogenousglucocorticoidexcess
AT isidoriandream covid19andcushingssyndromerecommendationsforaspecialpopulationwithendogenousglucocorticoidexcess
AT billerbeverlymk covid19andcushingssyndromerecommendationsforaspecialpopulationwithendogenousglucocorticoidexcess
AT grossmanashleyb covid19andcushingssyndromerecommendationsforaspecialpopulationwithendogenousglucocorticoidexcess
AT colaoannamaria covid19andcushingssyndromerecommendationsforaspecialpopulationwithendogenousglucocorticoidexcess